Shumaker S A, Dugan E, Bowen D J
Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1063, USA.
Control Clin Trials. 2000 Oct;21(5 Suppl):226S-32S. doi: 10.1016/s0197-2456(00)00083-0.
This paper identifies individual and systematic primary, secondary, and tertiary prevention approaches that can be used to enhance adherence in randomized controlled trials. Specifically, strategies such as these are discussed: careful screening during enrollment, use of a run-in period, fully informing participants of the study burden, explaining randomization, determining the participant's prior history with treatment interventions, establishing and using a tracking system, clearly specifying adherence measures, and staff training in communication and negotiation. These strategies have been gathered over time from our experiences working in multiple randomized controlled trials. Research on factors that promote or detract from adherence should be a standard part of randomized controlled trials. Control Clin Trials 2000;21:226S-232S
本文确定了可用于提高随机对照试验中依从性的个体及系统的一级、二级和三级预防方法。具体讨论了如下策略:入组时仔细筛选、采用导入期、向参与者充分说明研究负担、解释随机分组、了解参与者既往治疗干预史、建立并使用追踪系统、明确规定依从性测量方法,以及对工作人员进行沟通和谈判培训。这些策略是我们长期以来在多个随机对照试验工作中的经验总结。关于促进或妨碍依从性的因素的研究应成为随机对照试验的标准组成部分。《控制临床试验》2000年;21:226S - 232S